Translational Development Acquisition Corp.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Translational Development Acquisition
Blank Checks, SIC 6770
The entity operates as a blank check company formed to execute a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with an operating business. Because the organization functions as an investment vehicle, it does not manufacture commercial products, provide direct services, or maintain distinct business segments. In addition, the firm does not serve traditional commercial customers. Instead, its activities center on identifying, evaluating, and selecting prospective target entities that possess competitive advantages and growth potential.
Regarding scale, the enterprise maintains no commercial operations and employs no full-time personnel. Executive leadership consists of two officers who direct organizational affairs. Geographically, the company is incorporated as an exempted company in the Cayman Islands, where it is domiciled, while its custodial funds reside in a United States trust account.
Summary of the business section of Translational Development Acquisition's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Translational Development Acquisition Corp.
- Founded
- 2022
- Headquarters
- New York, NY
- Address
- 52 E 83rd St. 10028
- Phone
- (413) 204-2769
- Industry
- Blank Checks
- Fiscal year ends
- December 31
- Auditor
- WithumSmith+Brown, PC, New York, New York
Stock & identifiers
- Ticker
- TDAC
- Other tickers
- TDACU, TDACW
- Exchange
- Nasdaq
- IPO date
- Feb 13, 2025
- Shares outstanding
- 19M, Aug 14, 2026
- Public float
- $177.68M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 1926599
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Michael B. Hoffman | Chairman and CEO, Director | – |
| Avanindra Das | Chief Financial Officer | – |
| Christopher Kenneth Jarratt | Director | – |
| E. Premkumar Reddy | Director | – |
| Curtis T. Keith | Director | – |
| Matthew Kestenbaum | Director | – |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Dec 19, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |